Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells
- PMID:9655257
Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells
Abstract
To explore the regulation and function of D-type cyclins in breast cancer cells, the mouse mammary hyperplastic epithelial cell line TM2H was treated with 5 mM hexamethylenebisacetamide (HMBA), a polar differentiation factor. The resulting growth-inhibitory effect of HMBA was completely reversible and was analyzed in terms of percent cells in G1; association of D-type cyclins with cyclin-dependent kinase (cdk) 4 and cdk6; G1 kinase activity; association of retinoblastoma protein (pRb) and phosphorylated pRb with D-type cyclins; and association of p16INK4a, p15INK4b, and p27Kip1 with cdk4 and cdk6. Synchronized TM2H cells were examined at 0, 3, 5, 9, 12, and 24 h after exposure to 5 mM HMBA. Inhibition of DNA synthesis, as measured by thymidine uptake, was first observed at 5 h (40%) and peaked at 24 h (80%). Flow cytometry at 9 h showed treated cells to be in G1 arrest. Western blot analysis showed weakly detectable cyclin D1 but readily detectable cyclin D2 and D3 proteins at 0 h; thereafter, cyclin D2 and D3 protein levels remained higher while cyclin D1 levels declined significantly in treated versus untreated cells. By 5 h (early G1), HMBA had markedly inhibited cdk4 and cdk6 kinase activity (67% and 75%, respectively) in treated versus untreated cells. By 9 and 12 h, pRb levels had increased 3.4-fold in treated versus untreated cells. At 5 h, cyclin D-associated pRb was totally hypophosphorylated in treated cells and hyperphosphorylated in untreated cells. The levels of pRb associated with cyclin D2 and D3 increased 2.89-fold and 4.6-fold, respectively, in treated versus untreated cells. At 5 h, treated cells showed a fivefold increase in cdk4-associated p27Kip1 and, at 9 h, a fourfold increase in cdk6-associated p27Kip1 over control levels. In confirmation of these data, HMBA was found to inhibit the growth of Rb-positive Du/145Rb cells but not their Rb-negative parental Du/145 cells. The data suggest that HMBA-induced growth inhibition is due to multifactorial mechanisms involving decreases in total cyclin D1 and inhibition of cdk4 and cdk6 kinase activities through elevation of levels of cdk4- and cdk6-associated p27Kip1 and concomitant increases in hypophosphorylated pRb and stable cyclin D2/pRb and cyclin D3/pRb complexes that help maintain pRb in a functional state.
Similar articles
- Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.Phelps DE, Xiong Y.Phelps DE, et al.Cell Growth Differ. 1998 Aug;9(8):595-610.Cell Growth Differ. 1998.PMID:9716177
- Retinoic acid-mediated growth arrest of EBV-immortalized B lymphocytes is associated with multiple changes in G1 regulatory proteins: p27Kip1 up-regulation is a relevant early event.Zancai P, Cariati R, Rizzo S, Boiocchi M, Dolcetti R.Zancai P, et al.Oncogene. 1998 Oct 8;17(14):1827-36. doi: 10.1038/sj.onc.1202089.Oncogene. 1998.PMID:9778049
- Retinoblastoma protein-overexpressing HL60 cells resistant to 1,25-dihydroxyvitamin D3 display increased CDK2 and CDK6 activity and shortened G1 phase.Wang QM, Luo X, Kheir A, Coffman FD, Studzinski GP.Wang QM, et al.Oncogene. 1998 May 28;16(21):2729-37. doi: 10.1038/sj.onc.1201803.Oncogene. 1998.PMID:9652739
- [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].Viallard JF, Lacombe F, Belloc F, Pellegrin JL, Reiffers J.Viallard JF, et al.Cancer Radiother. 2001 Apr;5(2):109-29. doi: 10.1016/s1278-3218(01)00087-7.Cancer Radiother. 2001.PMID:11355576Review.French.
- [Cyclin D, CDK4 and p16 expression in colorectal cancer].Ikeda K, Monden T, Tsujie M, Izawa H, Yamamoto H, Ohnishi T, Ohue M, Sekimoto M, Tomita N, Monden M.Ikeda K, et al.Nihon Rinsho. 1996 Apr;54(4):1054-9.Nihon Rinsho. 1996.PMID:8920673Review.Japanese.
Cited by
- Mechanisms of suberoylanilide hydroxamic acid inhibition of mammary cell growth.Said TK, Moraes RC, Sinha R, Medina D.Said TK, et al.Breast Cancer Res. 2001;3(2):122-33. doi: 10.1186/bcr284. Epub 2000 Dec 22.Breast Cancer Res. 2001.PMID:11250759Free PMC article.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials